Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne M Fagan

Showing results (201-210 of 279) with videos related to

Pageof 28
Sort By:
Alzheimer'S & Dementia (New York, N. Y.)|April 25, 2017
Preclinical Alzheimer's disease and longitudinal driving declineCatherine M Roe, Ganesh M Babulal, Denise M Head, et al.
Brain : a Journal of Neurology|December 17, 2021
A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairmentAllan I Levey, Deqiang Qiu, Liping Zhao, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 26, 2011
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseReisa A Sperling, Paul S Aisen, Laurel A Beckett, et al.
JAMA Neurology|January 13, 2015
Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional studyAdam S Fleisher, Kewei Chen, Yakeel T Quiroz, et al.
Nature Neuroscience|July 9, 2021
Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disordersChengran Yang, Fabiana H G Farias, Laura Ibanez, et al.
Neurology|September 3, 2020
Sequence of Alzheimer disease biomarker changes in cognitively normal adults: A cross-sectional studyJingqin Luo, Folasade Agboola, Elizabeth Grant, et al.
Journal of Alzheimer'S Disease : JAD|July 24, 2022
Comparative Analysis of Alzheimer's Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based ApproachJigyasha Timsina, Duber Gomez-Fonseca, Lihua Wang, et al.
JAMA Neurology|June 30, 2015
Brain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease: A Cross-Sectional StudyYakeel T Quiroz, Aaron P Schultz, Kewei Chen, et al.
Brain : a Journal of Neurology|August 14, 2016
BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's diseaseYen Ying Lim, Jason Hassenstab, Carlos Cruchaga, et al.
The Lancet. Neurology|March 19, 2022
Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational studyEstrella Morenas-Rodríguez, Yan Li, Brigitte Nuscher, et al.
Pageof 28

Showing results (201-210 of 279) with videos related to

Sort By:
Pageof 28
Alzheimer'S & Dementia (New York, N. Y.)|April 25, 2017
Preclinical Alzheimer's disease and longitudinal driving declineCatherine M Roe, Ganesh M Babulal, Denise M Head, et al.
Brain : a Journal of Neurology|December 17, 2021
A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairmentAllan I Levey, Deqiang Qiu, Liping Zhao, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 26, 2011
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseReisa A Sperling, Paul S Aisen, Laurel A Beckett, et al.
JAMA Neurology|January 13, 2015
Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional studyAdam S Fleisher, Kewei Chen, Yakeel T Quiroz, et al.
Nature Neuroscience|July 9, 2021
Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disordersChengran Yang, Fabiana H G Farias, Laura Ibanez, et al.
Neurology|September 3, 2020
Sequence of Alzheimer disease biomarker changes in cognitively normal adults: A cross-sectional studyJingqin Luo, Folasade Agboola, Elizabeth Grant, et al.
Journal of Alzheimer'S Disease : JAD|July 24, 2022
Comparative Analysis of Alzheimer's Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based ApproachJigyasha Timsina, Duber Gomez-Fonseca, Lihua Wang, et al.
JAMA Neurology|June 30, 2015
Brain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease: A Cross-Sectional StudyYakeel T Quiroz, Aaron P Schultz, Kewei Chen, et al.
Brain : a Journal of Neurology|August 14, 2016
BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's diseaseYen Ying Lim, Jason Hassenstab, Carlos Cruchaga, et al.
The Lancet. Neurology|March 19, 2022
Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational studyEstrella Morenas-Rodríguez, Yan Li, Brigitte Nuscher, et al.
Pageof 28